Perinatal outcomes in pregnant women with COVID-19 in Siberia and the Russian Far East

Артымук, Н. В.; Belokrinitskaya, T. E.; Филиппов, О.С.; Фролова, Н. И.; Surina, M.N.

doi:10.1080/14767058.2021.1881954

Cited by 8 publications

(5 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…It is well known that pregnancy alters the immune system and its response to viral infection, and infection with coronavirus, in theory, could lead to more severe symptoms, especially in the third trimester [ 8 ]. One study found that the incidence of SARS-CoV-2 infection in pregnant women was 3.02 times greater than that in the general population [ 9 ], and Peng-hui Wang et al [ 10 ] pointed out that pregnant women with COVID-19 are more prone to develop severe conditions with a high mortality rate. Previous studies have shown that pregnant women infected with Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) or Middle East Respiratory Syndrome Coronavirus had a higher risk of developing adverse complications.…”

Section: Introductionmentioning

confidence: 99%

The association between pregnancy and COVID-19: A systematic review and meta-analysis

Wang

Sun

et al. 2022

The American Journal of Emergency Medicine

View full text Add to dashboard Cite

Section: Introductionmentioning

confidence: 99%

The association between pregnancy and COVID-19: A systematic review and meta-analysis

Wang

Sun

et al. 2022

The American Journal of Emergency Medicine

View full text Add to dashboard Cite

“…In the individual studies [27,31,40,54,55] that presented data on the causes of stillbirths, there was no clear evidence to suggest that COVID-19 increased the risk of SB unless there was significant maternal hypoxic or a terminal event that might lead to fetal compromise and intra-uterine fetal demise [29] a fact supported by the findings in the UKOSS data [40] highlighting the need for further information to evaluate the likely impact of significant hypoxia on possible SB rates [40].…”

Section: Discussionmentioning

confidence: 99%

A Meta-Analysis of the Global Stillbirth Rates during the COVID-19 Pandemic

Mohan,

Appiah-Sakyi,

Oliparambil

et al. 2023

JCM

View full text Add to dashboard Cite

COVID-19 has been shown to have variable adverse effects on pregnancy. Reported data on stillbirth rates during the pandemic have, however, been inconsistent—some reporting a rise and others no change. Knowing the precise impact of COVID-19 on stillbirths should help with the planning and delivery of antenatal care. Our aim was, therefore, to undertake a meta-analysis to determine the impact of COVID-19 on the stillbirth rate. Databases searched included PubMed, Embase, Cochrane Library, ClinicalTrials.gov, and Web of Science, with no language restriction. Publications with stillbirth data on women with COVID-19, comparing stillbirth rates in COVID-19 and non-COVID-19 women, as well as comparisons before and during the pandemic, were included. Two independent reviewers extracted data separately and then compared them to ensure the accuracy of extraction and synthesis. Where data were incomplete, authors were contacted for additional information, which was included if provided. The main outcome measures were (1) stillbirth (SB) rate in pregnant women with COVID-19, (2) stillbirth rates in pregnant women with and without COVID-19 during the same period, and (3) population stillbirth rates in pre-pandemic and pandemic periods. A total of 29 studies were included in the meta-analysis; from 17 of these, the SB rate was 7 per 1000 in women with COVID-19. This rate was much higher (34/1000) in low- and middle-income countries. The odds ratio of stillbirth in COVID-19 compared to non-COVID-19 pregnant women was 1.89. However, there was no significant difference in population SB between the pre-pandemic and pandemic periods. Stillbirths are an ongoing global concern, and there is evidence that the rate has increased during the COVID-19 pandemic, but mostly in low- and middle-income countries. A major factor for this is possibly access to healthcare during the pandemic. Attention should be focused on education and the provision of high-quality maternity care, such as face-to-face consultation (taking all the preventative precautions) or remote appointments where appropriate.

show abstract

“…The incidence of COVID-19 infection in pregnant women was 3.02 times greater than that in the general population [ 6 ]. Pregnancy causes several physiological changes and alters the immune system and its response to viral infection [ 7 , 8 ], which might increase the risk of any infection [ 9 ].…”

Section: Introductionmentioning

confidence: 99%

“…Pregnancy and SCT are both independently associated with more adverse COVID-19 outcomes [ 3 , 4 , 6 – 8 ]. However, the impact of the pandemic and factors affecting susceptibility to COVID-19 among pregnant women with SCT are unknown.…”

Section: Introductionmentioning

confidence: 99%

Risk and Protective Factors for COVID‐19 Infection among Pregnant Women with Sickle Cell Trait

Aldecoa,

Arsene,

Krishnamoorthy

et al. 2024

Advances in Hematology

View full text Add to dashboard Cite

Pregnant women and individuals with sickle cell trait (SCT) and underlying comorbidities are both independently more vulnerable to severe illness from coronavirus disease 2019 (COVID‐19) compared to nonpregnant women and those without SCT. However, our understanding of the specific factors influencing susceptibility to COVID‐19 infection among pregnant women with SCT is currently constrained by limited available data. This study aims to determine the risk and protective factors that influence the likelihood of COVID‐19 infection in this population. A retrospective analysis was done among 151 women with SCT in the reproductive age group. Multivariable analysis was performed to determine the various factors affecting COVID‐19 infection among pregnant women with SCT. The study found that COVID‐19‐vaccinated pregnant women with SCT had a 90% lower risk of contracting COVID‐19 and were 9 times more likely to have a COVID‐19 infection if they had a history of pulmonary conditions such as asthma or chronic obstructive pulmonary disease. The present study further emphasizes the importance of the COVID‐19 vaccine in preventing infection and safeguarding the health of pregnant women with SCT, particularly those with underlying comorbidities.

show abstract

Perinatal outcomes in pregnant women with COVID-19 in Siberia and the Russian Far East

Cited by 8 publications

References 12 publications

The association between pregnancy and COVID-19: A systematic review and meta-analysis

The association between pregnancy and COVID-19: A systematic review and meta-analysis

A Meta-Analysis of the Global Stillbirth Rates during the COVID-19 Pandemic

Risk and Protective Factors for COVID‐19 Infection among Pregnant Women with Sickle Cell Trait

Contact Info

Product

Resources

About